Cheap Drugs Not Enough to Fight Hepatitis C in Asia

[Inga Vesper] A survey released for World Hepatitis Day showed those with the greatest risk of HCV are the least likely to access treatment despite the availability of affordable medications across the region. Beyond cost, other barriers included time away from work, the added travel costs and out-of-pocket family care costs that would result from seeking treatment.

The World Bank Health Indicators

Provides global average of a wide range of health indicators, such as mortality rate, life expectancy and birth rate.